These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Kinetic and thermodynamic evaluation of phosphate ions binding onto sevelamer hydrochloride. Elsiddig R; Hughes H; Owens E; O' Reilly NJ; O'Grady D; McLoughlin P Int J Pharm; 2014 Oct; 474(1-2):25-32. PubMed ID: 25102115 [TBL] [Abstract][Full Text] [Related]
7. Determination of the binding parameter constants of Renagel capsules and tablets utilizing the Langmuir approximation at various pH by ion chromatography. Swearingen RA; Chen X; Petersen JS; Riley KS; Wang D; Zhorov E J Pharm Biomed Anal; 2002 Jun; 29(1-2):195-201. PubMed ID: 12062678 [TBL] [Abstract][Full Text] [Related]
8. Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Chertow GM; Burke SK; Lazarus JM; Stenzel KH; Wombolt D; Goldberg D; Bonventre JV; Slatopolsky E Am J Kidney Dis; 1997 Jan; 29(1):66-71. PubMed ID: 9002531 [TBL] [Abstract][Full Text] [Related]
9. Effect of RenaGel, a non-absorbable, cross-linked, polymeric phosphate binder, on urinary phosphorus excretion in rats. Rosenbaum DP; Holmes-Farley SR; Mandeville WH; Pitruzzello M; Goldberg DI Nephrol Dial Transplant; 1997 May; 12(5):961-4. PubMed ID: 9175050 [TBL] [Abstract][Full Text] [Related]
10. Molecular modeling studies of the binding characteristics of phosphates to sevelamer hydrochloride--assessing a novel technique to reduce phosphates contamination. Parker R; Odukale AA; Fisher D; Batich C; Ross E; Edwards J Int J Environ Res Public Health; 2006 Jun; 3(2):202-8. PubMed ID: 16823094 [TBL] [Abstract][Full Text] [Related]
11. A phosphate binding assay for sevelamer hydrochloride by ion chromatography. Mazzeo JR; Peters RM; Hanus MR; Chen X; Norton KA J Pharm Biomed Anal; 1999 May; 19(6):911-5. PubMed ID: 10698557 [TBL] [Abstract][Full Text] [Related]
12. Transient acid exposure increases sevelamer HCl phosphate binding. Ross EA; Scott WE; Odukale AA; Alba NA; Batich CD J Pharm Sci; 2007 Aug; 96(8):2154-60. PubMed ID: 17506513 [TBL] [Abstract][Full Text] [Related]
13. Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysis. Goldsmith DR; Scott LJ; Cvetković RS; Plosker GL Drugs; 2008; 68(1):85-104. PubMed ID: 18081374 [TBL] [Abstract][Full Text] [Related]
14. Bixalomer, a novel phosphate binder with a small swelling index, improves hyperphosphatemia in chronic kidney disease rat. Taniguchi K; Kakuta H Eur J Pharmacol; 2015 Nov; 766():129-34. PubMed ID: 26452517 [TBL] [Abstract][Full Text] [Related]